Cargando…

A systematic review of pharmacist input to metabolic syndrome screening, management and prevention

Background Metabolic syndrome is a cluster of factors that increase the risk of cardiovascular disease and include: diabetes and prediabetes, abdominal obesity, elevated triglycerides, low high-density lipoprotein cholesterol and high blood-pressure. However, the role of the pharmacist in the metabo...

Descripción completa

Detalles Bibliográficos
Autores principales: Al AdAwi, Rana Moustafa, Stewart, Derek, Ryan, Cristin, Tonna, Antonella Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476979/
https://www.ncbi.nlm.nih.gov/pubmed/32607719
http://dx.doi.org/10.1007/s11096-020-01084-3
_version_ 1783579799906680832
author Al AdAwi, Rana Moustafa
Stewart, Derek
Ryan, Cristin
Tonna, Antonella Pia
author_facet Al AdAwi, Rana Moustafa
Stewart, Derek
Ryan, Cristin
Tonna, Antonella Pia
author_sort Al AdAwi, Rana Moustafa
collection PubMed
description Background Metabolic syndrome is a cluster of factors that increase the risk of cardiovascular disease and include: diabetes and prediabetes, abdominal obesity, elevated triglycerides, low high-density lipoprotein cholesterol and high blood-pressure. However, the role of the pharmacist in the metabolic syndrome has not yet been fully explored. Aim of the review This systematic review aimed to critically appraise, synthesise, and present the available evidence on pharmacists’ input to the screening, prevention and management of metabolic syndrome. Method The final protocol was based on the “Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P)”. Studies published in English from January 2008 to March 2020 reporting any pharmacist activities in the screening, prevention or management of metabolic syndrome were included. Databases searched were Medline, Cumulative Index to Nursing and Allied Health Literature, International Pharmaceutical Abstracts, Cochrane and Google Scholar. Studies were assessed for quality by two researchers, data extracted and findings synthesised using a narrative approach. Results Of the 39,430 titles reviewed, ten studies were included (four were randomised controlled trials). Most studies focused on pharmacist input to metabolic syndrome screening and management. Screening largely involved communicating metabolic parameters to physicians. Management of metabolic syndrome described pharmacists collaborating with members of the multidisciplinary team. A positive impact was reported in all studies, including achieving metabolic syndrome parameter goals, reverting to a non-metabolic syndrome status and, improved medication adherence. The populations studied were paediatrics with risk factors, adults with comorbidities and psychiatric patients. Integration of the pharmacist within the multidisciplinary team, an easy referral process and accessibility of service were potential facilitators. Inadequate funding was the key barrier. Conclusion The studies describing pharmacist input in metabolic syndrome provide limited evidence of positive outcomes from screening and management as part of collaborative practice. Further work is required to provide more robust evidence of effectiveness and cost-effectiveness while considering key barriers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11096-020-01084-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7476979
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-74769792020-09-21 A systematic review of pharmacist input to metabolic syndrome screening, management and prevention Al AdAwi, Rana Moustafa Stewart, Derek Ryan, Cristin Tonna, Antonella Pia Int J Clin Pharm Review Article Background Metabolic syndrome is a cluster of factors that increase the risk of cardiovascular disease and include: diabetes and prediabetes, abdominal obesity, elevated triglycerides, low high-density lipoprotein cholesterol and high blood-pressure. However, the role of the pharmacist in the metabolic syndrome has not yet been fully explored. Aim of the review This systematic review aimed to critically appraise, synthesise, and present the available evidence on pharmacists’ input to the screening, prevention and management of metabolic syndrome. Method The final protocol was based on the “Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P)”. Studies published in English from January 2008 to March 2020 reporting any pharmacist activities in the screening, prevention or management of metabolic syndrome were included. Databases searched were Medline, Cumulative Index to Nursing and Allied Health Literature, International Pharmaceutical Abstracts, Cochrane and Google Scholar. Studies were assessed for quality by two researchers, data extracted and findings synthesised using a narrative approach. Results Of the 39,430 titles reviewed, ten studies were included (four were randomised controlled trials). Most studies focused on pharmacist input to metabolic syndrome screening and management. Screening largely involved communicating metabolic parameters to physicians. Management of metabolic syndrome described pharmacists collaborating with members of the multidisciplinary team. A positive impact was reported in all studies, including achieving metabolic syndrome parameter goals, reverting to a non-metabolic syndrome status and, improved medication adherence. The populations studied were paediatrics with risk factors, adults with comorbidities and psychiatric patients. Integration of the pharmacist within the multidisciplinary team, an easy referral process and accessibility of service were potential facilitators. Inadequate funding was the key barrier. Conclusion The studies describing pharmacist input in metabolic syndrome provide limited evidence of positive outcomes from screening and management as part of collaborative practice. Further work is required to provide more robust evidence of effectiveness and cost-effectiveness while considering key barriers. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s11096-020-01084-3) contains supplementary material, which is available to authorized users. Springer International Publishing 2020-06-30 2020 /pmc/articles/PMC7476979/ /pubmed/32607719 http://dx.doi.org/10.1007/s11096-020-01084-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Review Article
Al AdAwi, Rana Moustafa
Stewart, Derek
Ryan, Cristin
Tonna, Antonella Pia
A systematic review of pharmacist input to metabolic syndrome screening, management and prevention
title A systematic review of pharmacist input to metabolic syndrome screening, management and prevention
title_full A systematic review of pharmacist input to metabolic syndrome screening, management and prevention
title_fullStr A systematic review of pharmacist input to metabolic syndrome screening, management and prevention
title_full_unstemmed A systematic review of pharmacist input to metabolic syndrome screening, management and prevention
title_short A systematic review of pharmacist input to metabolic syndrome screening, management and prevention
title_sort systematic review of pharmacist input to metabolic syndrome screening, management and prevention
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476979/
https://www.ncbi.nlm.nih.gov/pubmed/32607719
http://dx.doi.org/10.1007/s11096-020-01084-3
work_keys_str_mv AT aladawiranamoustafa asystematicreviewofpharmacistinputtometabolicsyndromescreeningmanagementandprevention
AT stewartderek asystematicreviewofpharmacistinputtometabolicsyndromescreeningmanagementandprevention
AT ryancristin asystematicreviewofpharmacistinputtometabolicsyndromescreeningmanagementandprevention
AT tonnaantonellapia asystematicreviewofpharmacistinputtometabolicsyndromescreeningmanagementandprevention
AT aladawiranamoustafa systematicreviewofpharmacistinputtometabolicsyndromescreeningmanagementandprevention
AT stewartderek systematicreviewofpharmacistinputtometabolicsyndromescreeningmanagementandprevention
AT ryancristin systematicreviewofpharmacistinputtometabolicsyndromescreeningmanagementandprevention
AT tonnaantonellapia systematicreviewofpharmacistinputtometabolicsyndromescreeningmanagementandprevention